The incidence of atypical patterns ofBCR-ABL1rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)-Reference-Cited by-同舟云学术

The incidence of atypical patterns ofBCR-ABL1rearrangement and molecular-cytogenetic response to tyrosine kinase inhibitor therapy in newly diagnosed cases with chronic myeloid leukemia (CML)

Published:2018 Issue:2 Volume:53 Page:152
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Švabek Željka Tkalčić¹,Josipović Marina²,Horvat Ivana³,Zadro Renata⁴,Davidović-Mrsić Sanja¹

Affiliation:

1. Clinical Department of Laboratory Diagnostics, Division for Cytogenetics, University Hospital Centre Zagreb, Zagreb, Croatia.

2. Department of Laboratory Diagnostics, General Hospital “Dr. Josip Benčević”, Slavonski Brod, Croatia.

3. Clinical Department of Laboratory Diagnostics, Division of Laboratory Hematology and Coagulation, University Hospital Centre Zagreb, Zagreb, Croatia.

4. Department of Medical Biochemistry and Hematology, University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2018.53.2.152

Reference26 articles.

1. Controversies in the Treatment of CML in Children and Adolescents: TKIs versus BMT?

2. Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-α therapy or allogeneic bone marrow transplantation

3. BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

4. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant BCR-ABL and JAK2 V617F in a Patient with Myeloproliferative Neoplasm: A Case Report;Medicine & Health;2023-06-16

2. Genomic Mechanisms Influencing Outcome in Chronic Myeloid Leukemia;Cancers;2022-01-26

3. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series;Leukemia Research;2021-12

4. Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update;Frontiers in Genetics;2021-08-10